Company

Sanofi CEO Paul Hudson Rules Out GLP-1 Competition, Eyes Next-Gen Weight-Management Therapies

Policy / Regulatory

Corruption Investigations Target Former HSA Officials in Guizhou and Hainan Amid Nationwide Crackdown

CompanyDeals

Henlius Biotech Secures Exclusive Rights to Sermonix’s Lasofoxifene for Breast Cancer Treatment in China

CompanyDrug

GenFleet’s SLS009 Receives Fast-Track and Orphan Drug Designations from U.S. FDA for Lymphoma and Leukemia

CompanyDeals

GSK’s Acquisition of Aiolos Bio Bolsters Respiratory Medicine Portfolio with AIO-001

Company

WuXi AppTec Expands Peptide Manufacturing Capacity with Two New Plants in China

CompanyMedical Device

Sino Medical Sciences’ HT Supreme Drug-Eluting Stent System Gains Market Approval in Bangladesh

CompanyDrug

Novartis’s Cosentyx Secures Additional Indication for Psoriatic Arthritis in China

CompanyDrug

Pfizer and Genmab’s Tivdak Earns Priority Review from FDA for Full Registration

Company

International Society for Cell & Gene Therapy Comments on FDA’s CAR-T Investigation

CompanyHospital

Meizhong Jiahe Medical Debuts on Hong Kong Stock Exchange Below IPO Price

CompanyDrug

AbbVie Launches Continuous Infusion Therapy for Advanced Parkinson’s Disease in EU